Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 and clinical efficacy of continuous ciprofol infusion with ketamine for colon polyp ESD in elderly patients
ChiCTR2500102341Phase 4Not yet recruiting
- Sponsor
- Shanghai Xuhui District Central Hospital
- Start
- May 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ciprofol and ketamine in colonic polyp, sponsored by Shanghai Xuhui District Central Hospital. Primary endpoint: Dose of ciprofol at occurrence of positive reaction. Planned start May 2025; status: not yet recruiting.
02
Drugs
ciprofolketamine
03
Conditions
colonic polyp
Beyond the preview
Go deeper on ChiCTR2500102341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102341.